Handelsavisen
prelaunch
Companies Healthcare BIOPOR.CO
BI
BIOPOR.CO Nasdaq Copenhagen Medical Equipment, Supplies & Distribution

Bioporto A/S

kr1,18
Open in Charts → Attach watcher ⌖
DKK
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-213,7 %
ROE
-130,3 %
Net margin
-203,8 %
Debt / equity
0,12
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

BIOPOR.CO operates in the healthcare services and equipment industry, focusing on medical equipment, supplies, and distribution.

Business. BIOPOR.CO is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. It is listed on the Nasdaq Copenhagen exchange under the ticker symbol BIOPOR.CO. Specific details regarding operating segments, headquarters location, and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-130,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning BIOPOR.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to BIOPOR.CO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    BIOPOR.CO is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. It is listed on the Nasdaq Copenhagen exchange under the ticker symbol BIOPOR.CO. Specific details regarding operating segments, headquarters location, and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    BIOPOR.CO's capital structure is characterized by a low debt-to-equity ratio of 0.12, indicating a conservative leverage profile. The company holds substantial cash and equivalents of 54,893,000 DKK, which is significantly higher than its total liabilities of 30,173,000 DKK, resulting in a strong current ratio of 3.25. This liquidity position supports operational flexibility and short-term obligations. However, the company reported negative operating and free cash flows of -77,066,000 DKK and -79,609,000 DKK, respectively, indicating a cash outflow from operations.

    Profitability metrics show a challenging performance, with a return on equity of -1.3033 and a return on assets of -0.8813, both significantly below industry norms. The company's operating income of -86,094,000 DKK and net income of -82,117,000 DKK reflect a substantial loss, which is a concern for investors. Gross profit of 30,392,000 DKK is insufficient to cover operating expenses, highlighting inefficiencies in cost management.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to sector-specific risks and limits growth opportunities. The absence of capital expenditures suggests a current focus on maintaining operations rather than expanding capacity.

    Looking ahead, the company's revenue is projected to increase to 42,000,000 DKK, a 4.2% year-over-year growth, based on analyst estimates. However, the mean EBIT estimate of -63,112,000 DKK indicates continued losses, which could impact long-term sustainability. The company's negative operating cash flow and lack of capital expenditures suggest a need for strategic cost optimization or external financing to support future growth.

    Risk factors include a low liquidity risk and a low dilution potential, with no immediate filing-based liquidity or dilution flags detected. The company's low debt levels and strong cash reserves mitigate short-term financial risks. However, the continued negative net income and operating cash flow pose long-term sustainability concerns. No recent filings or transcripts were provided to assess recent events or strategic shifts.

    Key takeaways
    • BIOPOR.CO has a strong liquidity position with a current ratio of 3.25 and significant cash reserves.
    • The company is experiencing significant losses, with a return on equity of -1.3033 and a return on assets of -0.8813.
    • Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
    • Analysts project a 4.2% year-over-year revenue growth to 42,000,000 DKK, but continued losses are expected.
    • The company has low liquidity and dilution risks, but its negative operating cash flow and lack of capital expenditures suggest a need for strategic cost optimization or external financing.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    kr1,18
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    kr63.0M
    Net cash
    kr47.4M
    Current ratio
    3.2
    Debt / equity
    0.1
    ROA
    -88.1%
    ROE
    -1.3%
    Cash conversion
    94.0%
    CapEx / revenue
    0.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    12-month price targetkr1,75 · Median kr1,75
    Low kr1,75High kr1,75
    Operating income · consensus-63,1M DKK
    Revenue surprise
    −4,1 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Lowkr1,75
    Meankr1,75
    Mediankr1,75
    Highkr1,75
    Spotkr1,18
    +48.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-213,7 %Bottom quartile
    Net Margin-203,8 %Bottom quartile
    ROE-130,3 %Bottom quartile
    Capex / Rev0,0 %Above P75
    D/E0,12Above median
    Cash Conv0,94Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • BIOPOR.CO Market data — financials · 2026-05-27
    • Bioporto A/S Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BIOPOR.COCanonical
    Nasdaq Copenhagen · DKK

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage